A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus Who Are at High Risk of Progression to Severe Disease
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus Who Are at High Risk of Progression to Severe Disease
The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.
Key Inclusion Criteria:
Participants who have new onset or worsening (if present chronically) of at least 1 of the following signs and/or symptoms consistent with a viral acute respiratory infection within 72 hours prior to randomization: fever, nasal congestion, nasal discharge, sore throat, cough, sputum production, shortness of breath, or wheezing.
Participants diagnosed with RSV infection preferably using a rapid polymerase chain reaction (PCR) or other molecular-based diagnostic assay.
Has at least 1 of the following risk factors for severe RSV disease:
With the exception of the RSV disease, medically stable on the basis of medical history, physical examination, vital signs, and 12-lead electrocardiogram (ECG) performed at screening.
Key Exclusion Criteria:
Note: Other protocol-specified inclusion and exclusion criteria may apply.
Shionogiclintrials-admin@shionogi.co.jp800-849-9707
Tampa, Florida 336214-2869, United States
East Point, Georgia 30344-3604, United States
The Bronx, New York 10451, United States
CABA, Buenos Aires C1427CEA, Argentina
CABA, Buenos Aires C1430CKE, Argentina
San Miguel de Tucumán, Tucumán Province T4000IHE, Argentina
Montana, Sofia 3400, Bulgaria
Gabrovo, 5300, Bulgaria
Kasugai-Shi, Aiti 0568-56-5050, Japan
Nagoya-Shi Nakamura-Ku, Aiti 052-481-9921, Japan
Fukuoka-Shi Chuo-Ku, Fukuoka 092-707-2103, Japan
Fukuoka-Shi Hakata-Ku, Fukuoka 092-283-7777, Japan
Kitakyushu-Shi Yahatanishi-Ku, Fukuoka 093-611-5335, Japan
Kitakyushu-Shi, Fukuoka 093-391-1001, Japan
Takasaki-shi, Gunma 027-370-0777, Japan
Sapporo-Shi Toyohira-Ku, Hokkaidô 011-853-8322, Japan
Himeji-shi, Hyôgo 079-285-0111, Japan
Tsuchiura-Shi, Ibaraki 029-835-3002, Japan
Shiwa-gun, Iwate 019-672-1110, Japan
Kawasaki-Shi, Kanagawa 044-740-2717, Japan
Adachi-Ku, Tokyo 03-884-8888, Japan
Musashino, Tokyo 0422-36-3534, Japan
Nakano-ku, Tokyo 03-3389-2201, Japan
Nakano-Ku, Tokyo 03-3926-0007, Japan
Shibuya-Ku, Tokyo 03-5447-2477, Japan
Shibuya-Ku, Tokyo 03-6276-5385, Japan
Shinjuku-Ku, Tokyo 03-5368-0675, Japan
Suginami-ku, Tokyo 03-5347-7300, Japan
Toshima-Ku, Tokyo 03-3986-5501, Japan
Higashiokitama-gun, Yamagata 0238-54-0135, Japan
Tarnów, Lesser Poland Voivodeship 33-100, Poland
Chojncie, Pomeranian Voivodeship 86-900, Poland
Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship 27-400, Poland
Princess Crossing, Roodepoort 1724, South Africa
Neihu District, Taipei 114202, Taiwan